XMAW:LSE:LSE-Xtrackers MSCI AC World ESG Screened UCITS ETF 1C (GBX)

ETF | Others |

Last Closing

USD 3202

Change

-10.00 (-0.31)%

Market Cap

N/A

Volume

2.16K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+2.45 (+0.98%)

USD 292,109.69B
XNIF:LSE Xtrackers Nifty 50 Swap UCITS ..

+224.00 (+1.16%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

-2.75 (-1.41%)

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.04 (-0.24%)

USD 701.81B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.05 (-0.38%)

USD 636.56B
0R1I:LSE NVIDIA Corp.

-1.80 (-1.51%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+0.15 (+0.22%)

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

-0.09 (-0.28%)

USD 260.39B
0QZO:LSE 0QZO

-0.40 (-0.40%)

USD 258.54B

ETFs Containing XMAW:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.99% 21% F 29% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.99% 21% F 29% F
Trailing 12 Months  
Capital Gain 7.58% 60% D- 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.58% 57% F 58% F
Trailing 5 Years  
Capital Gain 102.88% 69% C- 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 102.88% 67% D+ 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 12.70% 70% C- 72% C
Dividend Return 12.70% 69% C- 72% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.71% 61% D- 77% C+
Risk Adjusted Return 108.41% 91% A- 95% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike